Clinical Trial Update: Validation of a Treatment Algorithm for Poor-Risk NSGCTnon Seminomatous Germ-cell Tumors [NA]

View source ↗

Summary

ClinicalTrials.gov reports an ongoing study validating a treatment algorithm for poor-risk non-seminomatous germ cell tumors. The status is Recruiting, with no …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-seminomatous Germ Cell Tumor

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Non-Seminomatous Germ Cell Tumor | NA | Status: RECRUITING